documents: FDA-2020-N-1082-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-1082-0001 FDA FDA-2020-N-1082 Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests Proposed Rule Amendment 2020-04-02T04:00:00Z 2020 4 2020-04-02T04:00:00Z 2020-06-02T03:59:59Z 2020-06-03T01:03:28Z 2020-06821 0 0 090000648448123d

Links from other tables